ophthalmologytimes2h
SpyGlass Pharma completes enrollment in Phase I/II study of its long-term drug delivery platform for glaucoma and ocular hypertension
SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...
How Musk’s DOGE can actually do some good
It is not possible to eliminate every law, regulation, committee or agency that deserves to exist. It's important to set ...
Pharmabiz6h
Boston Scientific WATCHMAN FLX LAAC device demonstrates superior bleeding risk reduction to OAC following a cardiac ablation in OPTION clinical trial
Marlborough, Massachusetts Tuesday, November 19, 2024, 17:00 Hrs [IST] ...
TCTMD20h
OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain
Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.
Irish Independent on MSN2h
Jeremy Clarkson ‘defies doctors’ orders’ to join thousands of protesting farmers
Jeremy Clarkson says he has defied doctors’ orders by joining thousands of farmers in London to protest against agricultural ...
ITV I'm A Celebrity campmates' cosmetic transformations - from cosmetic eye surgery to health-related Botox
As the I'm A Celebrity campmates settle into the Australian jungle for the new series, we take a look at the stars who have ...
stockhead19h
Dr Boreham’s Crucible: Can this aortic stenosis detection specialist keep things pumping post FDA approval?
With FDA approval in the bag for its AI-based aortic stenosis diagnostic tool, Echo IQ is focused on commercialisation over the coming years.